Latest filing published 09 Mar 2026 for NU Skin Enterprises, INC.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Steven Keith Hatchett (senior executive) discloses dealings in NU Skin Enterprises, Inc. to SEC (Form 4). The record holds 21 filings, for trades running from 15 February 2022 to 6 March 2026.
Both buying and selling appear: 2 purchases worth €89k, against 1 sale worth €255k. Sales outweigh purchases by €166k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 17 share grants and 1 option exercise.
Most recently, on 9 March 2026, the filings show a share grant in NU Skin Enterprises, Inc. The latest purchase dates back some time: it was published 340 days ago, on 12 November 2025. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations